High concentrations of cocaethylene (EC), the ethyl ester of benzoylecgonxne, were measured in the blood of individuals who had concurrently used cocaine and ethanol Since the powerful reinforcing effects of cocaine appear to be dependent on mhlbiUon of dopamine reuptake in brain, we compared the effects of EC on the doparmne uptake system and its behavioral effects with those of cocaine. EC was equlpotent to cocaine with respect to inhibition of binding of [3H]GBR 12395 to the dopanune reuptake complex, inhibition of [3H]dopamine uptake into synaptosomes and m its ability to increase extracellular dopamine concentratmn m the nucleus accumbens following ~ts systemic administratmn to rats. Moreover, in rats, EC and cocaine each increased locomotor actavity and rearing to the same extent following i.p admmistratmn. In self-administration stuches m primates, EC was approximately equipotent to cocaine in maintaining responding. The in vzvo formation of this active, transestenfied ethyl homolog of cocaine may contribute to the effects and consequences of combined cocaine and ethanol abuse
chromatographic peaks, which were presumptively ldenufied as EC, had been observed in these samples and blood concentrations initially approximated using cocaine as a standard. We identified additional samples from Yale-New Haven Hospital Emergency Room patients for study on the basis of urine benzoylecgonine and blood alcohol analyses.
Dru~ Analysis: Cocaine and EC concentrations were determined by reversed-phase ion pmrmg HPLC as previously reported (10) . Blood sample preparation for gas chromatography-mass spectrometry (GC/MS) was as previously described for gas chromatographic analysis of cocaine (11) . EC for use as an analyucal standard and for use m the neurochemical and behavioral studies, was synthesized by esterification of benzoylecgonme. Benzoylecgonine was refluxed for 6-10 hours in ethanol through which dry HC1 gas had been passed. The ethanol was evaporated and the acid residue washed w~th hexane to remove any ethyl benzoate The residue was then suspended in carbonate buffer, pH 9.6, and the EC (but not benzoylecgonme) extracted into hexane. Following back extraction into acid and re-extraction into hexane, the product was 97-99% pure by HPLC and GC/MS analysis, and free of any contaminating cocaine. In some instances, EC was subsequently crystalhzed from ether as the hydrochlonde. A electron impact mass spectrum showed a molecular ion at m/e 317 and other major ions at m/e 196 and m/e 212 which was consistent with pubhshed data (8) . Corresponding cocaine ions were at m/e 182, m/e 198 and rn/e 303. High resoluuon proton NMR confirmed the ethyl ester substltuuon for the methyl ester group of cocaine.
Binding and Uotake: [3H]Doparmne uptake and [3H]GBR binding were performed essentmlly as described previously (12) . This involved the preparation of P2 fraction from rat stnatum or nucleus accumbens. For [3H]dopamine uptake, the tissue was incubated with cocaine or EC and desipramme (100 nM) in Krebs phosphate buffer (pH 7.4) for 5 mm at 37°C before adding [3H]dopamine (40 nM, 37-40 Ci/mmol Dupont NEN). Two minutes later the uptake was terminated by rapid filtration through Whatman GF/C filters. The retained portion was washed and radioactivity trapped on the filter was counted. Non-specific binding was defined as the radioactwity on the filter following incubation of tissue and [3H]doparmne on ice. For [3HJGBR 12935 binding, tissue was incubated at 4°C for 15 hr with cocaine or EC and [3H]GBR 12935 (2 nM, 43 Ci/mmol, Dupont NEN, Boston, MA) in 50 mM Trls buffer containing 120 mM NaCI (pH 7.4). The incubation was terminated by vacuum filtration through Whatman GF/B filter paper. Each filter was rinsed and the radioactivity remaining on the filter was counted. Nonspecific binding was defined with 10 I.tM mazindol.
Microdlalysis in Rats (13) (14) (15) : Concentric style rmcrodmlys:s probes were constructed using Cuprophan (Enka, West Germany) hollow fibers (300 ~tm I.d., 330 ~tm o.d.) housed in a section of 23 gauge stainless steel tubing with an exposed &alysls surface 1.5-2 mm long. The perfuslon buffer was (in mM): KC1 2 4, NaC1 137, CaC12 1.2, MgC12 1.2, NaH2PO4 0.9, Na2HP04 1.4, ascorbic acid 0.3, pH 7.4 Rats were anesthetized with chloral hydrate (400 mg/kg i.p.), and placed in a stereotaxlc apparatus in the flat skull position. The coordinates to which the tip of the dialysis probe were lowered vs the top of the skull at bregma were +1 7A, 1.3 L, and -8.3 V. Body temperature was monitored by a rectal temperature probe and maintained with a heating pad. Following each experiment, the brain was removed and stored in formalin for later sectioning and staining to verify probe placement In the nucleus accumbens. Determination of dopamine concentrauon was accomplished using HPLC with electrochermcal detection as previously (13) . The routine hmit of detecuon was 2-3 fmols dopamme injected in a volume of 40 microliters.
Rodent Behavior: The behavioral ratings of locomotor actavity and rearing were used to determine whether the drug treatments resulted in activation (16) . Identical cardboard boxes were used as testing chambers for measunng rodent behavior. Quadrants were marked on the sides of the test chambers so that locomotor activity.could be measured by counting the crossings between sections. The rats were habituated to the test boxes for three hour periods two days before the test. Subjects were randomly assigned to one of three experimental groups destined to receive saline, cocaine or EC On the test day, each subject received its injection i.p. 5 mm before the test. The subjects were placed in the test box for 15 min. Behavioral ratangs were taken by one observer who was blind to the treatment Locomotor act:vity was defined as a crossing of quadrant markings on the rode of the test chamber Rearing was defined as lifting both forepaws off the ground.
Self-Administration by Primates: The reinforcing effects of EC were evaluated in three rhesus monkeys who were tr~ned to respond on levers and receive i.v. injections of cocaine on a fixed ratio 30 time out 45 sec schedule of drug delivery, as described previously (17) . Each selfadministration session consisted of four 25 rain components of drug availability, signalled by a red stimulus hght over the lever. Components were separated by 10 mm. blackout periods of no drug availability. The infumon duration, and hence the dose of drug dehvered, was different in each of the four sesmon components. The standard dose range for cocaine was 0.001 to 0.03 mg/kg/injection. EC was substituted for cocaine m single dally sesmons over a dose range of 0.001 to 0.03 mg/kg/injection m two monkeys, and over a dose range of 0.003 to 0.1 mgtkg/injection in a third monkey. Data reported are for the observations of EC substitution and for the sessions of cocaine availability immediately preceding EC substitutaon.
Statistics: Data were analyzed by ANOVA followed, where appropriate, by Newman-Keuls test with p<0.05 as the level of sigmficance.
Results
EC concentrations in the seven human postmortem samples ranged from 73 to 1447 ng/rnl (Table I ) and the identity of the metabolite established by GC/MS (Figure 1 ). Note that m four instances, EC concentrations exceeded those of the parent compound. Ten of seventeen random emergency room blood samples in which the urine and plasma had been positive for benzoylecgonine and ethanol respectively, showed EC by HPLC. Of the seven EC negative samples, mx were either negatwe or showed less than 5 ng/ml of cocaine. Of fourteen additmnal samples that were positive by cocaine screening but were negatwe for ethanol, thirteen showed no EC and one sample showed a trace To exclude the possibility of in wtro artifact, we incubated 400 ng/ml of both cocaine and benzoylecgonme in blood containing ethanol (500 mg/dl) at 37°C for one hour and at refrigerator temperature for 24 days. To approximate the gastric environment following alcohol ingestion, we incubated 4 g/dl alcohol with 500 ng/ml cocaine and benzoylecgonme m 0.1 M HC1 at 37°C for two hours. EC was not formed in any of these experiments. On the basis of these findings, we initiated a series of studies in order to defme the pharmacological properties of EC. There was no significant difference between EC and cocaine in inhibiting the binding of the specific dopamine uptake blocker, [3H]GBR 12935 to rat striatal membranes (1(250 300 nM), ( Figure 2B ). Similarly, EC was also equipotent to cocaine (IC50 250 nM) in inhibiting [aH]dopamine uptake into rat synaptosomes prepared from either striatum or nucleus accumbens (Figure 2A) . Following systemic administration of EC to rats, there was a significant increase (four-fold) in extracellular dopamine concentrations in the nucleus accumbens measured by microdialysis (Figure 3 ). These increases in dopamine levels were not significantly different from those observed after the same dose of cocaine. In rats, EC and cocaine both potently increased locomotor acuvlty and rearing compared to sahne. There was no significant difference between EC and cocaine on locomotor activity or rearing. Behavior of rats following i.p. injection of cocaine (10 mg/kg, n=5), EC (10 mg/kg, n=5) or saline (n=5). * and + denote sigmficant differences from saline treated group.
Rates of responding in rhesus monkeys were maintained by both i.v. cocaine and by EC when these drugs were delivered contingently on lever press responses. Although there was some individual variation in the doses of EC that maintained maximum rates of responding, each of the three monkeys showed rates of EC-mamtained responding that were similar to or slightly higher than rates maintained by cocaine (Fig. 6) . On average, the maximum rate-maintaining dose of EC was 0.01 mg/kg/injectlon as compared to a dose of 0.03 mg/kg/injection of cocaine. A dose of EC above that maintaining maximum rates produced response decrements, a finding that is found with virtually all drugs that maintain self-administration behavior, including cocaine in this procedure Mean rates of responding maintained by cocaine or EC in rhesus monkeys (n=3). Rate of responding maintained in each of the tested monkeys is also shown. Drugs delivered contingent on lever responses.
Di scu sslon
The high concentrations of EC found in human blood were comparable to and in many Instances well in excess of cocaine concentrations that are known to be associated with significant pharmacological activity (18, 19) . EC was found in most samples associated with evidence of concurrent cocaine and ethanol use and was not present when the latter was absent. Those instances where EC was not present despite the occurrence of ethanol and benzoylecgonine, cocaine was either also absent from the blood or only present in trace amounts suggesting that EC may well have been completely cleared as well. In that instance where we saw a trace of EC (less than 10 ng/ml) despite the absence of alcohol, we suspect that the alcohol had been eliminated by the time the sample was obtained. Our incubation studies exclude the possibility of a storage artifact. EC is not a natural alkaloid of the coca leaf nor is street cocaine contaminated with EC.
Removal of the methyl ester group of cocaine to form benzoylecgonine results in an almost complete loss of affinity for the monoamme uptake carrier (20) ; however, it is not known what effect other substatutions at this position have. Since EC has such close structural homology to cocaine, we postulated that it might have a similar spectrum of neurochemical and behavioral properties. We found that EC was equipotent to cocaine in its inhibition of specific ligand binding to the dopamine reuptake complex, inhibition of dopamine uptake into synaptosomes and in its ability to increase extracellular dopamine concentrations following administration to rats. The mechanism for the reinforcing properties of cocaine are thought to involve inhibition of dopamlne reuptake with consequent elevation of synapttc dopamine levels m pathways mechatmg reward (20) (21) (22) (23) (24) (25) (26) (27) (28) . The similar stimulation of rat locomotor activity and rearing observed after systemic administration of EC or cocaine, suggested that flus metabolite tmght share cocaine's psychostimulant properties.
To put our neurochermcal f'mdlngs into perspecnve, it was essential to estabhsh whether EC was reinforcing in a primate model (29) . The implications of our rodent data were confn'rned by the self-admlnistrauon studies m primates. EC was equlpotent to cocaine and showed a similar dose response curve m maintmning lever responding in rhesus monkeys. Following cocaineethanol abuse by humans, ethanol would be present m the body in addition to cocaine and EC The effects of these drugs in combmauon was not directly addressed by the described experiments Cocaine is rapidly elirmnated with an approximate plasma T 1/2 of one hour (30, 31) and its acute effects disappear even more rapidly. Depending upon its rate of fonnatton and elimination and its neurochemical properues, EC might be expected to add to cocaine's effects, prolong them and/or exhibit cross tolerance (32, 33) or cross sensit~zatlon (34) It might also better cross the blood brain bamer as a consequence of greater hydrophoblclty Since repeated use of cocaine and alcohol dunng a binge may be associated with exposure to recurrent pulses of cocaine and EC, sensinzataon and cross senmtlZatlon might contribute to the effects of this drug combination There have been relatively few pubhshed studies of the effects of combined cocmne and ethanol administration. One study (35) and two recent prehminary reports (36, 37) have indicated that some effects were enhanced and one indicated that subjectave effects were greater following adrmmstration of cocmne and ethanol in combinanon than after either drug alone (37) A recent preliminary report indicated that cocaine enhanced ethanol's threshold lowering effect on brain stimulation reward (38) . This information is only suggesuve and there are other posmble explanataons for these observations including a &rect effect of ethanol on doparmne mediated reward pathways (39) . In any event, further characterization of EC's neuropharmacology could enhance our understanding of the very prevalent problem of combined cocaxne-ethanol abuse
